Skip to main content
. 2018 Nov 3;8(4):76. doi: 10.3390/metabo8040076

Table 4.

Patient demographics for plasma VLCDCA 28:4 measurements. All patients included in the study were Caucasian.

Group Age (Yr. ±SD) N Number of Females
Pilot-Controls 54.5 ± 8.9 15 9
Pilot-Kidney 65.8 ± 12.0 7 1
Pilot-Breast 59.4 ± 7.4 7 7
Pilot-GBM 54.6 ± 5.6 12 5
Pilot-CRC 69.9 ± 6.9 9 5
Validation-Controls 57.3 ±5.8 23 14
Validation-Pancreatic 69.1 ± 9.3 18 11
Validation-CRC 57.3 ± 8.1 28 22
Validation-Kidney 55.7 ± 8.9 9 2